Garofalo Health Care S.p.A. (BIT:GHC)
Italy · Delayed Price · Currency is EUR 5.60
+0.10 (1.82%)
Last updated: Jul 28, 2026, 10:16 AM CET
Garofalo Health Care Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 21.81 | 23.57 | 21.85 | 20.87 | 21.43 | 18.84 |
Depreciation & Amortization | 28.43 | 27.9 | 25.33 | 21.44 | 18.36 | 15.52 |
Other Adjustments | 6.39 | 2.48 | 2.85 | 4 | 3.61 | 0.65 |
Change in Receivables | 25.05 | -4.84 | -12.67 | 4.96 | -1.91 | -2.71 |
Changes in Inventories | 0.21 | -0.15 | -0.49 | 0.17 | 0.19 | 0.34 |
Changes in Accounts Payable | -12.7 | -4.19 | -1.44 | -2.55 | 3.88 | -0.88 |
Changes in Other Operating Activities | -4.33 | 4.28 | -0.42 | 1.1 | -1.69 | 4.55 |
Operating Cash Flow | 64.77 | 49.04 | 34.99 | 50.01 | 43.87 | 36.31 |
Operating Cash Flow Growth | 159.98% | 40.15% | -30.02% | 13.99% | 20.81% | 58.14% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -29.61 | -30.92 | -18.29 | -15.44 | -13.84 | -23.2 |
Sale of Property, Plant & Equipment | -0.25 | 0.27 | 0.79 | 0.27 | 0.32 | 0.33 |
Purchases of Intangible Assets | -2.97 | -2.62 | -3.3 | -1.71 | -1.13 | -1.47 |
Cash Acquisitions | - | - | - | -49.96 | -20.88 | -67.68 |
Other Investing Activities | 0.11 | -0.71 | 2.45 | -1.07 | 0.03 | -0.11 |
Investing Cash Flow | -47.93 | -33.97 | -18.36 | -67.91 | -35.5 | -92.13 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | -6.27 | -0.13 | -16.57 | 0.43 | -2.82 | 6.93 |
Net Short-Term Debt Issued (Repaid) | -6.27 | -0.13 | -16.57 | 0.43 | -2.82 | 6.93 |
Long-Term Debt Issued | 9 | - | 177.8 | 40.68 | 16.59 | 179.77 |
Long-Term Debt Repaid | -1.23 | -1.13 | -160.59 | -23.7 | -22.26 | -148.06 |
Net Long-Term Debt Issued (Repaid) | 7.77 | -1.13 | 17.21 | 16.97 | -5.67 | 31.71 |
Issuance of Common Stock | - | - | - | - | - | 40.94 |
Repurchase of Common Stock | -0.48 | -1.3 | -0.85 | -1.49 | -2.98 | -3.15 |
Net Common Stock Issued (Repurchased) | -0.48 | -1.3 | -0.85 | -1.49 | -2.98 | 37.79 |
Common Dividends Paid | - | -7.59 | - | - | - | - |
Other Financing Activities | -5.09 | -11.71 | -12.45 | -6.71 | -6.76 | -4.18 |
Financing Cash Flow | -11.76 | -21.85 | -12.66 | 9.2 | -18.23 | 72.25 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 5.09 | -6.78 | 3.98 | -8.7 | -9.86 | 16.43 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 35.16 | 18.12 | 16.7 | 34.57 | 30.04 | 13.12 |
Free Cash Flow Growth | 613.80% | 8.51% | -51.68% | 15.10% | 129.01% | 9.58% |
FCF Margin | 7.16% | 3.72% | 3.55% | 9.38% | 9.31% | 4.62% |
Free Cash Flow Per Share | 0.40 | 0.20 | 0.19 | 0.39 | 0.34 | 0.15 |
Levered Free Cash Flow | 5.22 | 19.08 | 27.03 | 42.94 | 19.84 | 53.8 |
Unlevered Free Cash Flow | -1.04 | 28.25 | 36.1 | 33.04 | 31.71 | 18.5 |